I have topped up.
I still believe in this BOD, integrity intact as far as I'm concerned.
Release looked identical to RAP announcement ( RA Chair ), when FDA said go away and come back with more convincing argument.
RA obviously believe's bad news should be delivered short, straight to the solar plexus, see who stands upright again.
Big picture. Covid-19 treatment is huge news. Majority of retail investors, of which there are now plenty thanks to Scott, would never have heard of PharmAust, and a possible deal on K9 cancer. They will be taking a look at PAA for the first time on the back of Covid treatment news ... and that looks very very good. I suspect news of Elanco deal, while devastating for LTH, will be met with a shrug of the shoulders by these newbies.
So tragically, several LTH's that deserve better will exit, newbies will enter and make multi-bags when the Covid19 trials deliver.
All IMO.
Ann: Elanco Option Update, page-84
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $94.80M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $140.9K | 586.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12010 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 4.08 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 23.5¢ | 164909 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PAA (ASX) Chart |